Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (201-210 of 307) with videos related to

Pageof 31
Sort By:
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationHonglin Song, Ed Dicks, Susan J Ramus, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
International Journal of Cancer|July 17, 2010
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancerMaria Notaridou, Lydia Quaye, Dimitra Dafou, et al.
Gene|October 8, 2013
A common nonsense mutation of the BLM gene and prostate cancer risk and survivalAndrzej Antczak, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Journal of Medical Genetics|June 18, 2020
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancerHonglin Song, Ed M Dicks, Jonathan Tyrer, et al.
Iscience|February 24, 2026
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancerAaron J Bernstein, Renske Keeman, Amber N Hurson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Pageof 31

Showing results (201-210 of 307) with videos related to

Sort By:
Pageof 31
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationHonglin Song, Ed Dicks, Susan J Ramus, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
International Journal of Cancer|July 17, 2010
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancerMaria Notaridou, Lydia Quaye, Dimitra Dafou, et al.
Gene|October 8, 2013
A common nonsense mutation of the BLM gene and prostate cancer risk and survivalAndrzej Antczak, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Journal of Medical Genetics|June 18, 2020
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancerHonglin Song, Ed M Dicks, Jonathan Tyrer, et al.
Iscience|February 24, 2026
Compartment-specific tumor-infiltrating immune cells and prognosis in breast cancerAaron J Bernstein, Renske Keeman, Amber N Hurson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian CancerStacey J Winham, Ailith Pirie, Yian Ann Chen, et al.
Pageof 31